Geode Capital Management
TMCI icon

Geode Capital Management’s Treace Medical Concepts TMCI Stock Holding History

Geode Capital Management’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.28M Sell
573,796
-437,047
-43% -$1.2M ﹤0.01% 3160
2026
Q1 		$1.35M Sell
1,010,843
-133,529
-12% -$266K ﹤0.01% 3263
2025
Q4 		$2.8M Sell
1,144,372
-2,035
-0.2% -$8.84K ﹤0.01% 3044
2025
Q3 		$7.69M Buy
1,146,407
+26,826
+2% +$175K ﹤0.01% 2564
2025
Q2 		$6.58M Buy
1,119,581
+32,438
+3% +$211K ﹤0.01% 2591
2025
Q1 		$9.12M Buy
1,087,143
+24,378
+2% +$219K ﹤0.01% 2347
2024
Q4 		$7.91M Buy
1,062,765
+22,159
+2% +$148K ﹤0.01% 2505
2024
Q3 		$6.04M Sell
1,040,606
-21,413
-2% -$138K ﹤0.01% 2664
2024
Q2 		$7.06M Buy
1,062,019
+74,292
+8% +$600K ﹤0.01% 2538
2024
Q1 		$12.9M Buy
987,727
+23,424
+2% +$312K ﹤0.01% 2166
2023
Q4 		$12.3M Buy
964,303
+50,720
+6% +$512K ﹤0.01% 2220
2023
Q3 		$12M Buy
913,583
+105,875
+13% +$1.94M ﹤0.01% 2148
2023
Q2 		$20.7M Buy
807,708
+113,445
+16% +$2.93M ﹤0.01% 1834
2023
Q1 		$17.5M Buy
694,263
+87,617
+14% +$2.06M ﹤0.01% 1890
2022
Q4 		$13.9M Buy
606,646
+33,583
+6% +$773K ﹤0.01% 2028
2022
Q3 		$12.6M Buy
573,063
+171,851
+43% +$3.32M ﹤0.01% 2071
2022
Q2 		$5.75M Buy
401,212
+39,633
+11% +$668K ﹤0.01% 2627
2022
Q1 		$6.84M Buy
361,579
+4,705
+1% +$91.5K ﹤0.01% 2607
2021
Q4 		$6.65M Buy
356,874
+140,036
+65% +$2.89M ﹤0.01% 2723
2021
Q3 		$5.83M Buy
216,838
+1,845
+0.9% +$50.8K ﹤0.01% 2819
2021
Q2 		$6.72M Buy
+214,993
New +$6.84M ﹤0.01% 2733

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Geode Capital Management's TMCI Position: Q2 2026 in Review

Geode Capital Management reduced its Treace Medical Concepts (TMCI) stake by 43% in Q2 2026, selling an estimated $1.2M and leaving 573,796 shares worth $2.28M. The position accounts for ﹤0.01% of the portfolio, ranked #3160.

Geode Capital Management first reported a position in TMCI in Q2 2021 and has held it in 21 quarters since. The position peaked at $20.7M in Q2 2023. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Geode Capital Management held 573,796 shares of Treace Medical Concepts worth $2.28M as of Q2 2026.
  • Geode Capital Management sold 437,047 Treace Medical Concepts shares in Q2 2026, an estimated $1.2M.
  • Treace Medical Concepts made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3160 holding.
  • Geode Capital Management first reported a position in Treace Medical Concepts in Q2 2021 and has held it in 21 quarters since.
  • Geode Capital Management's Treace Medical Concepts position peaked at $20.7M in Q2 2023.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.